A teaching program to prevent pneumonia from the breathing machine
Part of Infections, Lungs & breathing clinical trials.
This trial tests a teaching program for ICU staff and patients to help prevent pneumonia that can develop from being on a breathing machine. If you are on a ventilator, this program may keep you safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been on a breathing machine (ventilator) for more than 48 hours.
- You did not have pneumonia when you were admitted to the hospital.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving probiotics to patients on a breathing machine (mechanical ventilation) can help prevent pneumonia. It is for adults who are on a ventilator after a recent head injury, stroke, or brain bleed.
This trial tests an “antibiotic stewardship” approach—choosing and adjusting antibiotics in a smarter way—for a first episode of pneumonia in patients on a breathing machine. It may help ensure the right antibiotics are used at the right time, while avoiding unnecessary or overly broad treatment.
This study tests whether a special care routine can prevent lung infections (pneumonia) in patients on breathing machines in the intensive care unit.
This trial looks at how well doctors followed current guidelines to diagnose ventilator-associated pneumonia (a lung infection from a breathing tube) in ICU patients between 2022 and 2024. It aims to improve future care.
This study is testing a way to reduce the chance of a certain breathing problem (called NAV) in babies who need a breathing machine in the NICU. If your baby has been on the machine for two days or more, they may be able to join.
This trial tests whether giving preventive antibiotics to adults on breathing machines lowers the risk of developing pneumonia during ventilation. It is a double-blind study, meaning neither you nor your doctor will know if you receive the antibiotic or a placebo.
Hear when a new Ventilator Associated Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.